[EN] USE OF NEW LIPOXYGENASE INHIBITORS<br/>[FR] UTILISATION DE NOUVEAUX INHIBITEURS DE LIPOXYGENASE
申请人:BIOLIPOX AB
公开号:WO2005084656A1
公开(公告)日:2005-09-15
There is provided a use of a compound of formula (I), wherein R<1>, R<2>, R<3 >and R<4> have meanings given in the description, and pharmaceutically-acceptable salts thereof, for the manufacture of a medicament for the treatment of a disease in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.